ARTEMISMED.BO(ARTEMISMED.BO)
ARTEMISMED.BO
No analyst ratings available
No analyst price targets available for ARTEMISMED.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $13.15B | $15.77B | $23.40B |
| Low | $12.86B | $15.27B | $23.40B |
| High | $13.44B | $16.26B | $23.40B |
| EBITDA Avg | $3.00B | $3.59B | $5.33B |
| Low | $2.93B | $3.48B | $5.33B |
| High | $3.06B | $3.71B | $5.33B |
| EBIT Avg | $2.33B | $2.79B | $4.14B |
| Low | $2.27B | $2.70B | $4.14B |
| High | $2.38B | $2.88B | $4.14B |
| Net Income Avg | $1.30B | $1.82B | $2.57B |
| Low | $1.30B | $1.75B | $2.57B |
| High | $1.30B | $1.88B | $2.57B |
| EPS Avg | $8.20 | $11.50 | $16.30 |
| Low | $8.20 | $11.08 | $16.30 |
| High | $8.20 | $11.92 | $16.30 |
| Analysts (Rev / EPS) | 2 / 1 | 4 / 2 | 3 / 1 |